Altered motor awareness in Parkinson's disease with progressive micrographia

Hiroyuki Hamada1, Kyohei Mikami2, Wen Wen3

  • 1Department of Human and Engineered Environmental Studies, Graduate School of Frontier Sciences, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba, 277-8563, Japan.

Neuropsychologia
|June 12, 2026
PubMed

Insights

Progressive micrographia (PM) in Parkinson's disease is linked to reduced motor awareness. This may involve altered sensory feedback processing, suggesting new therapeutic targets beyond standard dopaminergic treatments.

Area of Science:

  • Neuroscience
  • Movement Disorders
  • Motor Control

Background:

  • Micrographia, characterized by small handwriting, is a common motor symptom in Parkinson's disease (PD).
  • Two subtypes, consistent micrographia (CM) and progressive micrographia (PM), are proposed to have distinct mechanisms.
  • While CM is linked to bradykinesia and improves with dopaminergic treatment, PM persists and may involve altered sensorimotor processing, but its relation to motor awareness is unclear.

Purpose of the Study:

  • To investigate differences in motor control awareness between people with Parkinson's disease (PwP) and healthy controls (HC).
  • To determine if these differences are associated with micrographia subtypes (CM and PM).

Main Methods:

  • Forty-five PwP and twenty age-matched HC performed a handwriting task and a control detection task (CDT).
  • The CDT assesses the ability to distinguish self-generated from externally generated movements.
  • PwP were classified into no micrographia, CM, or PM groups based on handwriting metrics.

Main Results:

  • Healthy controls (HC) demonstrated significantly higher accuracy on the CDT compared to people with Parkinson's disease (PwP).
  • Individuals with progressive micrographia (PM) exhibited particularly reduced performance on the CDT.
  • Lower CDT accuracy in PwP suggests impaired motor awareness.

Conclusions:

  • Progressive micrographia (PM) in Parkinson's disease is associated with reduced motor awareness.
  • This deficit may stem from altered prediction-feedback integration in sensorimotor processing.
  • Findings suggest potential for therapeutic strategies targeting motor awareness to complement dopaminergic treatments for PM.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...